Sohomoy Sohomoy
Search Results
See All Results
  • Join
    Sign In
    Sign Up
    Search
    Night Mode

Search

Discover new people, create new connections and make new friends

  • News Feed
  • Mine
    • My Blogs
    • My Products
    • My Offers
    • My Jobs
    • My Courses
  • EXPLORE
  • Pages
  • Groups
  • Events
  • Reels
  • Blogs
  • Market
  • Offers
  • Jobs
  • Courses
  • Movies
  • Posts
  • Blogs
  • Users
  • Pages
  • Groups
  • Events
  • Rutuja Deshmukh added blog Other
    2026-06-23 11:05:39 -
    Keytruda Market Trends in PD-1 Inhibitor-Based Treatments
    The global Keytruda Market was valued at USD 31.4 billion in 2025 and is projected to grow from USD 32.7 billion in 2026 to USD 25.0 billion by 2033, registering a CAGR of -3.8% from 2026 to 2033. While Keytruda (pembrolizumab) remains one of the most successful immunotherapy drugs globally, the market is expected to face headwinds over the forecast period due to patent expiration,...
    0 Comments 0 Shares 141 Views
    Please log in to like, share and comment!
  • Anuj Mrfr added blog Health
    2026-08-06 06:49:19 -
    Keytruda Market - PD-1 Checkpoint Inhibition and Cancer Immunotherapy
    Market Overview The global Keytruda (pembrolizumab) market is experiencing growth driven by checkpoint immunotherapy dominance, cancer indications expansion, and clinical success documentation. The Keytruda market is projected to exceed USD 32.8 billion through 2030, fueled by pembrolizumab approvals exceeding 25 indications, patient populations exceeding 1 million annually, and breakthrough...
    0 Comments 0 Shares 25 Views
    Please log in to like, share and comment!
  • Shiwani Kumari added blog Health
    2026-04-09 08:36:37 -
    Keytruda Market Analysis: Unveiling the Immunotherapy Landscape
    Keytruda Market Analysis: Unveiling the Immunotherapy Landscape The Keytruda Market analysis reveals a rapidly evolving immunotherapy sector, fueled by increasing cancer prevalence and an enhanced understanding of checkpoint inhibitors. Keytruda, a PD-1 inhibitor developed by Merck & Co., has gained approval for multiple cancer types, including non-small cell lung cancer, head and neck...
    0 Comments 0 Shares 132 Views
    Please log in to like, share and comment!
  • Prajwal Kadam added blog Other
    2026-08-12 10:06:40 -
    Keytruda Market: Advanced Clinical Research Shapes the Next Era of Oncology Treatment
    In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...
    0 Comments 0 Shares 25 Views
    Please log in to like, share and comment!
© 2026 Sohomoy English
English Bangla
About Terms Privacy Contact Us Support Center Directory